Hugely popular weight-loss jabs like Wegovy have been making headlines for enabling people to manage diabetes and excess weight along with other benefits, scientists say.Increasingly recommended by ...

The FDA approves a new maintenance dosing regimen for lecanemab (Leqembi; Eisai) in patients with early-stage Alzheimer ...

Worry has now turned to desperation for a family of an 80-year-old man with severe dementia – last seen near his home south ...

As research continues, those involved say this would be a game changer, especially for patients with very limited options.